Gilead Sciences Inc (GILD) reports robust financial performance with significant sales growth in key therapeutic areas and ...

On Tuesday, Gilead Sciences, Inc. (GILD) stock saw a modest uptick, ending the day at $85.21 which represents a slight increase of $0.78 or 0.92% from the prior close of $84.43. The stock opened at ...

Future Financial Wealth Managment LLC acquired a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in ...

Cognizant (NASDAQ: CTSH) and Palo Alto Networks are partnering to deliver AI-driven cybersecurity capabilities and services for enterprises across industries. The partnership combines Cognizant's ...

Despite major advances in scientific innovation, access to care and growth of health systems, there are still millions of people around the world living with HIV.

Genomics, Inc. , a leader in single cell and spatial biology, today announced preliminary select results for the third quarter ended September 30, ...

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

People-first nurse leader and burnout expert Dr. Andrea Coyle, DNP, NE-BC launches an inspiring and transformative weekly podcast, "The Shift with Dr. Andrea Coyle." As a nurse for over 30 years, Dr.

Dear reader, in 2024, the pharmaceutical industry has undergone significant transformations due to rapid advancements in drug ...

Echo IQ's stock boosted 25% following FDA approval for its AI tool, EchoSolv AS, which aids in detecting severe Aortic ...

South Korean author Han Kang wins 2024 Nobel Prize in Literature for ‘poetic prose on historical trauma’. (Image: ...

The global pulmonary arterial hypertension treatment market is on track to achieve significant growth over the next decade, with a projected valuation of USD 7,224.4 million by 2033. This expansion ...